The present invention falls within the field of biomedical technology, and in particular relates to modified oligonucleotides and a compound that can be used for synthesizing same and a method for modifying oligonucleotides. The present invention also relates to the use of the modified oligonucleotides for preventing and/or treating diseases associated with the liver in a subject.
